We are live on ! Find out more
BC

Broadfin Capital Portfolio holdings

AUM $747M
1-Year Est. Return 100.56%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+100.56%
3 Year Est. Return
+297.65%
5 Year Est. Return
+365.91%
10 Year Est. Return
–
AUM
$511M
AUM Growth
–
Cap. Flow
+$509M
Cap. Flow %
99.56%
Top 10 Hldgs %
53.04%
Holding
51
New
51
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
NTUS
Natus Medical Inc
NTUS
+$35.3M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$33.6M
3
ASRT
Assertio
ASRT
+$31.3M
4
ANGO icon
AngioDynamics
ANGO
+$29M
5
NVDQ
Novadaq Technologies Inc.
NVDQ
+$25.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 73.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRRX
26
DELISTED
DURECT Corp
DRRX
$6.3M 1.23%
+599,910
New +$6.68M
MASI
27
DELISTED
Masimo
MASI
$5.32M 1.04%
+250,837
New +$5.28M
CRDC
28
DELISTED
CARDICA INC COM NEW (DE)
CRDC
$4.87M 0.95%
+438,572
New +$5.52M
ASMB icon
29
Assembly Biosciences
ASMB
$509M
$4.44M 0.87%
+30,831
New +$4.83M
GMED icon
30
Globus Medical
GMED
$10.4B
$4.19M 0.82%
+248,767
New +$3.84M
INSY
31
DELISTED
Insys Therapeutics, Inc.
INSY
$4.15M 0.81%
+900,000
New +$3.3M
MMSI icon
32
Merit Medical Systems
MMSI
$4.4B
$3.72M 0.73%
+333,734
New +$3.58M
INSM icon
33
Insmed
INSM
$23.1B
$3.49M 0.68%
+291,740
New +$2.98M
QLTI
34
DELISTED
QLT Inc
QLTI
$3.45M 0.67%
+784,893
New +$6.34M
IPCI
35
DELISTED
Intellipharmaceuticals International Inc.
IPCI
$3.33M 0.65%
+196,078
New +$3.61M
TSRX
36
DELISTED
TRIUS THERAPEUTICS INC COM STK (DE)
TSRX
$3.28M 0.64%
+404,427
New +$2.99M
POZN
37
DELISTED
POZEN INC
POZN
$3.21M 0.63%
+641,000
New +$3.2M
DRTX
38
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
$2.76M 0.54%
+383,227
New +$2.81M
SPNC
39
DELISTED
Spectranetics Corp
SPNC
$2.59M 0.51%
+138,720
New +$2.62M
WINT
40
DELISTED
Windtree Therapeutics Inc
WINT
$2.53M 0.5%
+119,000
New +$2.93M
GWPH
41
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.47M 0.48%
+280,000
New +$2.48M
FLNA
42
Filana Therapeutics
FLNA
$43.5M
$2.21M 0.43%
+142,857
New +$3.02M
ANTH
43
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$1.95M 0.38%
+65,625
New +$2.45M
OSUR icon
44
OraSure Technologies
OSUR
$281M
$1.94M 0.38%
+500,000
New +$2.23M
ALBO
45
DELISTED
Albireo Pharma Inc
ALBO
$1.92M 0.38%
+15,326
New +$1.59M
RMTI icon
46
Rockwell Medical
RMTI
$26.2M
$1.91M 0.37%
+4,801
New +$2.04M
CUTR
47
DELISTED
Cutera, Inc.
CUTR
$1.9M 0.37%
+215,962
New +$2.22M
INFI
48
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1.9M 0.37%
+117,172
New +$3.63M
ZGNX
49
DELISTED
Zogenix, Inc.
ZGNX
$1.83M 0.36%
+133,562
New +$1.71M
CASM
50
DELISTED
CAS Medical Systems, Inc.
CASM
$368K 0.07%
+220,544
New +$408K
1
2
3

Similar funds

CBU
CIBC Bank USA Chicago, Illinois $756M AUM 24.68% 1-Year Est. Return
CONA
Capital One National Association New York $756M AUM
MP
Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return
SC
Selz Capital New York $570M AUM 35.56% 1-Year Est. Return
KGACF
Kopernik Global All-Cap Fund Tampa, Florida $558M AUM
BPWA
Beacon Pointe Wealth Advisors Newport Beach, California $543M AUM 23.61% 1-Year Est. Return
TRAM
Tuscan Ridge Asset Management Chicago, Illinois $984M AUM 25.8% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Broadfin Capital's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Broadfin Capital, which disclosed 51 positions worth $511M. Its ten largest holdings account for 53% of the portfolio.

Its largest position is Natus Medical Inc: 2,590,992 shares worth $35.4M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets.

  • Broadfin Capital's largest Q2 2013 buy was Natus Medical Inc: 2,590,992 shares worth $35.4M.
  • Broadfin Capital's ten largest holdings make up 53% of its $511M portfolio in Q2 2013.
  • Broadfin Capital disclosed 51 positions in Q2 2013, its first 13F filing on record.

Based on Broadfin Capital's 13F filing for Q2 2013, filed 14 Aug 2013.